Network Pharmacology Integrated Molecular Docking Reveals the Antiosteosarcoma Mechanism of Biochanin A

Figure 5

KEGG pathway enrichment analysis for the targets in biochanin A treating osteosarcoma (p value<0.01 and FDR<0.01). The y-axis shows significantly enriched KEGG pathways of the target genes, and the x-axis shows the Rich factor. Rich factor stands for the ratio of the number of target genes belonging to a pathway to the number of all the annotated genes located in the pathway. The higher Rich factor represents the higher level of enrichment. The size of the dot indicates the number of target genes in the pathway, and the color of the dot reflects the different FDR range.